688105.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:00):

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials...

Stats
Dzisiejszy wolumen	2.29M
Średni wolumen	2.57M
Kapitalizacja rynkowa	11.10B
EPS	CNY0.0100 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-699.00
ATR14	CNY0.0840 (0.30%)

Wolumen Korelacja

Długi: -0.04 (neutral)

Krótki: -0.45 (neutral)

Signal:(45.344) Neutral

Nanjing Vazyme Biotech Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanjing Vazyme Biotech Korelacja - Waluta/Towar

-0.72
( moderate negative )

-0.15
( neutral )

0.00
( neutral )

0.36
( neutral )

0.22
( neutral )

Nanjing Vazyme Biotech Finanse

Annual	2023
Przychody:	CNY1.28B
Zysk brutto:	CNY822.18M (64.05 %)
EPS:	CNY-0.180

FY	2023
Przychody:	CNY1.28B
Zysk brutto:	CNY822.18M (64.05 %)
EPS:	CNY-0.180

FY	2022
Przychody:	CNY3.57B
Zysk brutto:	CNY2.46B (68.88 %)
EPS:	CNY1.490

FY	2021
Przychody:	CNY1.87B
Zysk brutto:	CNY1.52B (81.22 %)
EPS:	CNY1.870

Financial Reports:

No articles found.

Nanjing Vazyme Biotech

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.